← Browse by Condition
Medical Condition

vagina neoplasm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06023862 Phase 2
Recruiting

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Enrollment
198 pts
Location
Japan, Singapore, So...
Sponsor
Yonsei University
View Trial →